Biolux Research Ltd,Vancouver, British Columbia, Canada, has raised CAD $2.4 million in newfunding for the company. The funds were raised through a debt issuethat is convertible to common shares at the company’s option, and wasfully subscribed by existing shareholders of the company.
The proceeds of the financing are designated as working capital tocontinue development of the OrthoPulse™, a full-mouth, extraoralphototherapy device designed for use with traditional orthodontictreatment to facilitate faster tooth movement and reduced treatmenttimelines. The funds will also be used to complete initial orthodontichuman trials, expand new studies and trials, and develop new technologyand additional intellectual property. The new funds are expected tosupport the company through the commercial launch of the OrthoPulse.
For more information on this and other orthodontic companies, visit our Buyer’s Guide.
